Craig Collard - 31 Jan 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
Issuer symbol
HRTX
Transactions as of
31 Jan 2025
Net transactions value
$0
Form type
4
Filing time
04 Feb 2025, 12:43:47 UTC
Previous filing
22 Jan 2025
Next filing
26 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +1,113,240 $0.000000 1,113,240 31 Jan 2025 Common Stock 1,113,240 $1.70 Direct F1
transaction HRTX Restricted Stock Units Award $0 +556,620 $0.000000 556,620 31 Jan 2025 Common Stock 556,620 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).
F2 The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).